WO1995000122A1 - Transdermal delivery system package - Google Patents

Transdermal delivery system package Download PDF

Info

Publication number
WO1995000122A1
WO1995000122A1 PCT/US1994/006681 US9406681W WO9500122A1 WO 1995000122 A1 WO1995000122 A1 WO 1995000122A1 US 9406681 W US9406681 W US 9406681W WO 9500122 A1 WO9500122 A1 WO 9500122A1
Authority
WO
WIPO (PCT)
Prior art keywords
release liner
transdermal
transdermal delivery
delivery device
liner
Prior art date
Application number
PCT/US1994/006681
Other languages
French (fr)
Inventor
Dan W. Connors
Jia Chen
Scott A. Huie
Original Assignee
Cygnus Therapeutic Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cygnus Therapeutic Systems filed Critical Cygnus Therapeutic Systems
Priority to EP94920731A priority Critical patent/EP0711153A1/en
Priority to AU71727/94A priority patent/AU7172794A/en
Priority to JP7502908A priority patent/JPH09501909A/en
Publication of WO1995000122A1 publication Critical patent/WO1995000122A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches

Definitions

  • This invention relates generally to a package for a transdermal delivery system and, in particular, to a release liner and pouch for use with multiple transdermal delivery systems.
  • Transdermal delivery systems deliver substances to a user's tissues and/or blood stream through the user's skin.
  • Examples are NICOTROL ® nicotine transdermal systems and MINITRAN ® nitroglycerin transdermal systems, both available from Cygnus Therapeutic Systems.
  • Such systems are typically formed as a flexible patch containing the substance within a reservoir. The patch attaches to the user with adhesive. Contact between the patch's active face and the user's skin permits the substance to transfer from the reservoir to the user at a rate determined in part by the construction of the patch and in part by the nature of the substance.
  • the substance within the transdermal delivery system may be adversely affected by contact with light, water, air, or airborne substances.
  • Packaging must be provided, therefore, to prevent loss or degradation of the substance within the system's reservoir.
  • One prior art packaging approach is described in U.S. Patent No. 5,077,104.
  • Transdermal delivery systems may be provided to the user with adhesive already applied to the delivery side of the patch.
  • the system's packaging must therefore also prevent degradation of the adhesive and inadvertent attachment of the patch to the wrong object.
  • Transdermal delivery systems are therefore typically releasably mounted on liners, as shown in U.S. Patent No. 4,915,102 and European Patent Application No. 401 949.
  • transdermal delivery systems have a limited life, and multiple systems may be needed by a single user to accomplish the purpose for which the system was prescribed. What is needed, therefore, is a way to package multiple transdermal delivery systems together.
  • the devices are adhesive patches mounted on a release liner.
  • the liner surface is chosen so that it will not adhere to the adhesive on the devices. Rather, the devices may be peeled off easily by the user.
  • the release liner is preferably perforated or scored to permit a portion of the liner below each device to be torn off by the user.
  • the device may be lifted from the liner by the torn-off portion.
  • the torn-off portion of the liner is itself removed from the device only after the uncovered portion of the device is applied to the user's skin.
  • Figure 1(a) is a top elevational view of the transdermal delivery system package of this invention designed to hold multiple transdermal delivery systems.
  • Figure 1(b) is a top elevational view of the transdermal delivery system package of this invention designed to hold a single transdermal delivery system.
  • Figure 2 is a side cross-sectional view of the preferred embodiment of this invention.
  • Figure 3(a) is a top elevational view of a single transdermal delivery system showing how the package may be used to apply the system.
  • Figure 3 (b) is a bottom elevational view of the single transdermal system of Figure 3(a).
  • Transdermal delivery devices 10 are mounted on a release liner 12 so that the devices' substance delivery surfaces 13 face toward liner 12 and the devices' top protective surface 11 face award from liner 12.
  • release liner 12 is made from polyester, polyethylene, polystyrene, polycarbonate or paper coated with silicone or a fluorochemical compound, or a combination of these materials.
  • devices 10 each have an internal reservoir layer 14, a bottom adhesive layer 15, and a top protective layer 16 in a manner known in the art.
  • Devices 10 and liner 12 are preferably stored in an air-tight, resealable bag 18 made of a plastic film or a foil laminate.
  • Bag 18 may include a plastic zipper or zip-lock mechanism 19.
  • Bag 18 may also include a non- resealable seal mechanism (not shown) that must be unsealed by the user the first time the package is opened.
  • Liner 12 has scores or perforations 20 that permit portions 22 of the liner to be torn away from liner 12. Perforations 20 run beneath a portion of each device 10, as shown in Figure 1. At least part of each liner portion 22 is not covered by a device 10. In use, the devices and release liner are removed from the resealable bag.
  • a single device may be removed from the release liner by tearing liner 12 along one of the perforated lines 20, and lifting the device 10 off the liner 12 with the torn-off portion 22.
  • torn-off portion 22 provides a means for the user to hold device 10 without actually coming into contact with the device.
  • the portion of device 10 not covering torn-off portion 22 may be placed at, and adhered to, the chosen site on the user's skin. Thereafter, torn-off portion 22 may be removed, and the remaining portion of device 10 may be adhered to the. user's skin.
  • the liner and devices may be placed back inside bag 18, and the bag may be resealed.
  • transdermal delivery systems examples include systems delivering natural or synthetic estrogens, progestins, or combinations of the two; systems delivering anti-hypertensives for high blood pressure; systems delivering nitroglycerin; and systems delivering nicotine compounds. Modifications to the invention may be made without departing from the scope of the invention. For example, other shapes and configurations of the entire release liner and of the removable portion of the release liner may be used.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

This invention is a new packaging system for transdermal devices (10). In the preferred embodiment, the devices are adhesive patches mounted on a release liner (12). The liner surface is chosen so that it will not adhere to the adhesive on the devices. Rather, the devices may be peeled off easily by the user. The release liner (12) is preferably perforated (20) or scored to permit a portion (22) of the liner below each device to be torn off by the user. The device may be lifted from the liner by using the torn off portion as a handle. The torn off portion of the liner is itself removed from the device only after the uncovered portion of the device is applied to the user's skin.

Description

TRANSDERMAL DELIVERY SYSTEM PACKAGE
Background of the Invention
This invention relates generally to a package for a transdermal delivery system and, in particular, to a release liner and pouch for use with multiple transdermal delivery systems.
Transdermal delivery systems deliver substances to a user's tissues and/or blood stream through the user's skin. Examples are NICOTROL® nicotine transdermal systems and MINITRAN® nitroglycerin transdermal systems, both available from Cygnus Therapeutic Systems. Such systems are typically formed as a flexible patch containing the substance within a reservoir. The patch attaches to the user with adhesive. Contact between the patch's active face and the user's skin permits the substance to transfer from the reservoir to the user at a rate determined in part by the construction of the patch and in part by the nature of the substance.
The substance within the transdermal delivery system may be adversely affected by contact with light, water, air, or airborne substances. Packaging must be provided, therefore, to prevent loss or degradation of the substance within the system's reservoir. One prior art packaging approach is described in U.S. Patent No. 5,077,104.
Transdermal delivery systems may be provided to the user with adhesive already applied to the delivery side of the patch. The system's packaging must therefore also prevent degradation of the adhesive and inadvertent attachment of the patch to the wrong object. Transdermal delivery systems are therefore typically releasably mounted on liners, as shown in U.S. Patent No. 4,915,102 and European Patent Application No. 401 949.
One prior art way of facilitating the handling and attachment adhesive patch drug delivery systems was to provide a cut in the patch's release liner (such as an "S" cut, a straight cut, etc.) to make the removal of the release liner easier. Similarly, another prior art approach was to make the release liner larger than the patch, such as by providing an extending tab. Both approaches, however, require some finger contact with the adhesive/drug surface.
To ensure that the substance within the transdermal delivery system reservoir is delivered only to the desired application site on the user, and to avoid contamination or degradation of the adhesive surface (especially for multiple-day wear) , it may be desirable to provide a way for the user to apply the system without coming in contact with the patch's adhesive delivery surface. One approach to this problem is shown by some prior art bandage products in which one part of a multiple-part release liner may be removed from a portion of the adhesive surface. The remaining portion of the release liner is removed only after the earlier-exposed portion of the adhesive surface has been attached to the patient.
Finally, transdermal delivery systems have a limited life, and multiple systems may be needed by a single user to accomplish the purpose for which the system was prescribed. What is needed, therefore, is a way to package multiple transdermal delivery systems together. Suππnary of the Invention
This invention meets these and other needs by providing a new packaging system for transdermal devices. In the preferred embodiment, the devices are adhesive patches mounted on a release liner. The liner surface is chosen so that it will not adhere to the adhesive on the devices. Rather, the devices may be peeled off easily by the user.
The release liner is preferably perforated or scored to permit a portion of the liner below each device to be torn off by the user. The device may be lifted from the liner by the torn-off portion. The torn-off portion of the liner is itself removed from the device only after the uncovered portion of the device is applied to the user's skin.
Brief Description of the Drawings
Figure 1(a) is a top elevational view of the transdermal delivery system package of this invention designed to hold multiple transdermal delivery systems.
Figure 1(b) is a top elevational view of the transdermal delivery system package of this invention designed to hold a single transdermal delivery system.
Figure 2 is a side cross-sectional view of the preferred embodiment of this invention.
Figure 3(a) is a top elevational view of a single transdermal delivery system showing how the package may be used to apply the system.
Figure 3 (b) is a bottom elevational view of the single transdermal system of Figure 3(a).
Detailed Description of the Preferred Embodiments
This invention provides a system for mounting and storing single or multiple transdermal delivery devices. A preferred embodiment of the invention is shown in Figures 1-3. Transdermal delivery devices 10 are mounted on a release liner 12 so that the devices' substance delivery surfaces 13 face toward liner 12 and the devices' top protective surface 11 face award from liner 12. In the preferred embodiment, release liner 12 is made from polyester, polyethylene, polystyrene, polycarbonate or paper coated with silicone or a fluorochemical compound, or a combination of these materials. As shown in Figure 2, devices 10 each have an internal reservoir layer 14, a bottom adhesive layer 15, and a top protective layer 16 in a manner known in the art. Devices 10 and liner 12 are preferably stored in an air-tight, resealable bag 18 made of a plastic film or a foil laminate. Bag 18 may include a plastic zipper or zip-lock mechanism 19. Bag 18 may also include a non- resealable seal mechanism (not shown) that must be unsealed by the user the first time the package is opened. Liner 12 has scores or perforations 20 that permit portions 22 of the liner to be torn away from liner 12. Perforations 20 run beneath a portion of each device 10, as shown in Figure 1. At least part of each liner portion 22 is not covered by a device 10. In use, the devices and release liner are removed from the resealable bag. A single device may be removed from the release liner by tearing liner 12 along one of the perforated lines 20, and lifting the device 10 off the liner 12 with the torn-off portion 22. As seen in Figure 3, torn-off portion 22 provides a means for the user to hold device 10 without actually coming into contact with the device. The portion of device 10 not covering torn-off portion 22 may be placed at, and adhered to, the chosen site on the user's skin. Thereafter, torn-off portion 22 may be removed, and the remaining portion of device 10 may be adhered to the. user's skin.
If any unused devices 10 remain on the release liner, the liner and devices may be placed back inside bag 18, and the bag may be resealed.
Examples of transdermal delivery systems that may be used with the package of this invention include systems delivering natural or synthetic estrogens, progestins, or combinations of the two; systems delivering anti-hypertensives for high blood pressure; systems delivering nitroglycerin; and systems delivering nicotine compounds. Modifications to the invention may be made without departing from the scope of the invention. For example, other shapes and configurations of the entire release liner and of the removable portion of the release liner may be used.

Claims

We claim:
1. A mounting system for a transdermal device comprising: a release liner, the release liner having means for removing a first portion of the release liner from a second portion of the release liner, and means on the release liner for releasably receiving an adhesive- backed transdermal device so that a first portion of the transdermal device is removably mounted on the first portion of the release liner and a second portion of the transdermal device is removably mounted on the second portion of the release liner.
2. The mounting system of claim 1 wherein the means for removing a first portion of the release liner comprises means for separating the first portion of the release liner from the second portion of the release liner along a predetermined line.
3. The mounting system of claim 2 wherein the means for separating comprises a perforation formed in the release liner along the predetermined line.
4. The mounting system of claim 1 further comprising handle means for holding the second portion of the release liner when the first portion of the release liner has been separated therefrom.
5. The mounting system of claim 4 wherein the handle means comprises an area on the second portion of the release liner that remains uncovered when the transdermal device is mounted thereon.
6. A transdermal delivery device package comprising: a first transdermal delivery device removably mounted on a release liner, a first portion of the first transdermal delivery device covering a first portion of the release liner and a second portion of the first transdermal delivery device covering a second portion of the release liner; and means for separating the first portion of the release liner from the second portion of the release liner.
7. The package of claim 6 further comprising a second transdermal delivery device removably mounted on the release liner, a first portion of the second transdermal device covering a third portion of the release liner and a second portion of the transdermal delivery device covering a fourth portion of the release liner; and means for separating the third portion of the release liner from the fourth portion of the release liner.
8. The package of claim 6 further comprising a resealable pouch adapted to contain the transdermal delivery device and the release liner.
9. A method for applying a transdermal delivery device to a site on a user comprising the following steps: providing a transdermal delivery device having an active face mounted on a release liner; separating a first portion of the release liner from the transdermal device to expose a first portion of the active face of the transdermal device while leaving a second portion of the active face of the transdermal device mounted on a second portion of the release liner; attaching the first portion of the active face of the transdermal device to the site on the user; separating the second portion of the release liner from the second portion of the active face of the transdermal device; and attaching the second portion of the active face of the transdermal device to the site on the user.
10. A method of packaging transdermal devices comprising the following steps: providing a release liner having a surface from which the transdermal devices can be removed; forming means for separating a first portion of the release liner from a second portion of the release liner; mounting a transdermal delivery device on the release liner so that a first portion of the transdermal delivery device is mounted on the first portion of the release liner and a second portion of the transdermal delivery device is mounted on the second portion of the release liner.
11. The method of claim 10 wherein the forming step comprises forming means for separating the first portion of the release liner from the second portion of the release liner along a predetermined line.
12. The method of claim 10 further comprising the steps of forming means for separating a third portion of the release liner from a fourth portion of the release liner; mounting a second transdermal delivery device on the release liner so that a first portion of the second transdermal delivery device is mounted on the third portion of the release liner and a second portion of the second transdermal delivery device is mounted on the fourth portion of the release liner.
PCT/US1994/006681 1993-06-24 1994-06-14 Transdermal delivery system package WO1995000122A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP94920731A EP0711153A1 (en) 1993-06-24 1994-06-14 Transdermal delivery system package
AU71727/94A AU7172794A (en) 1993-06-24 1994-06-14 Transdermal delivery system package
JP7502908A JPH09501909A (en) 1993-06-24 1994-06-14 Transdermal delivery system package

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8292693A 1993-06-24 1993-06-24
US08/082,926 1993-06-24

Publications (1)

Publication Number Publication Date
WO1995000122A1 true WO1995000122A1 (en) 1995-01-05

Family

ID=22174343

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1994/006681 WO1995000122A1 (en) 1993-06-24 1994-06-14 Transdermal delivery system package

Country Status (5)

Country Link
EP (1) EP0711153A1 (en)
JP (1) JPH09501909A (en)
AU (1) AU7172794A (en)
CA (1) CA2166191A1 (en)
WO (1) WO1995000122A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998025257A1 (en) * 1996-12-04 1998-06-11 Hexal Ag Flat transdermal medicated self-adhesive patch
US5950830A (en) * 1994-12-21 1999-09-14 Ethical Pharmaceuticals (U.K.) Limited Packaging for patches
DE10056234A1 (en) * 2000-11-13 2002-05-29 Lohmann Therapie Syst Lts Primary packaging for transdermal therapeutic systems or medical plasters
WO2007101659A1 (en) * 2006-03-09 2007-09-13 Grünenthal GmbH Easy-to-handle plaster containing an active substance
WO2014013344A2 (en) * 2012-07-16 2014-01-23 Nometics Inc. Multi-unit and calendar pouching of transdermal patches
US9186335B2 (en) 2002-07-30 2015-11-17 Ucb Pharma Gmbh Hot melt TTS for administering rotigotine
WO2018126170A1 (en) * 2016-12-30 2018-07-05 Euromed, Inc. Adhesive patch containing an improved release liner system
US10251844B2 (en) 1998-03-30 2019-04-09 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system and method of use thereof for treating parkinsonism

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2358246A (en) * 1937-12-23 1944-09-12 Nicolle Charles Plastic material wrapper
US3247957A (en) * 1964-08-17 1966-04-26 Hospital Supply And Dev Compan Sterile packaging and the like
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2358246A (en) * 1937-12-23 1944-09-12 Nicolle Charles Plastic material wrapper
US3247957A (en) * 1964-08-17 1966-04-26 Hospital Supply And Dev Compan Sterile packaging and the like
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5950830A (en) * 1994-12-21 1999-09-14 Ethical Pharmaceuticals (U.K.) Limited Packaging for patches
WO1998025257A1 (en) * 1996-12-04 1998-06-11 Hexal Ag Flat transdermal medicated self-adhesive patch
AU725503B2 (en) * 1996-12-04 2000-10-12 Hexal Ag Flat self-adhering drug patches
US10251844B2 (en) 1998-03-30 2019-04-09 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system and method of use thereof for treating parkinsonism
US10322093B2 (en) 1998-03-30 2019-06-18 Ucb Biopharma Sprl Method for producing a transdermal therapeutic system which contains a D2 agonist
DE10056234A1 (en) * 2000-11-13 2002-05-29 Lohmann Therapie Syst Lts Primary packaging for transdermal therapeutic systems or medical plasters
US9186335B2 (en) 2002-07-30 2015-11-17 Ucb Pharma Gmbh Hot melt TTS for administering rotigotine
WO2007101659A1 (en) * 2006-03-09 2007-09-13 Grünenthal GmbH Easy-to-handle plaster containing an active substance
WO2014013344A2 (en) * 2012-07-16 2014-01-23 Nometics Inc. Multi-unit and calendar pouching of transdermal patches
WO2014013344A3 (en) * 2012-07-16 2014-03-27 Nometics Inc. Multi-unit and calendar pouching of transdermal patches
WO2018126170A1 (en) * 2016-12-30 2018-07-05 Euromed, Inc. Adhesive patch containing an improved release liner system
CN110402127A (en) * 2016-12-30 2019-11-01 优而美公司 Patch containing improved release liner system

Also Published As

Publication number Publication date
AU7172794A (en) 1995-01-17
CA2166191A1 (en) 1995-01-05
JPH09501909A (en) 1997-02-25
EP0711153A1 (en) 1996-05-15

Similar Documents

Publication Publication Date Title
US5511689A (en) Dispensing device for adhesive-backed articles
EP0699127B1 (en) Self-adhesive laminate
US7521586B2 (en) Packaging for adhesive-sided articles to allow one-handed application
JP4129519B2 (en) Medical adhesive bandage supply system
EP0356614B1 (en) Dermal applicator
US4787380A (en) Delivery system and package for a self adhering polymer medical dressing
US7659439B2 (en) Bandage package and dispenser
CA1132422A (en) Medical dressing
EP0241119A1 (en) Skin patch assembly
EP0181333B1 (en) Topical dressings
EP0921775A1 (en) Medical adhesive composite and package
EP0802777A1 (en) Self-adhesive laminate
US20070173752A1 (en) Integrated package
JP2003525076A (en) Packaging supplies for wet tissues or similar consumables
EP0711153A1 (en) Transdermal delivery system package
HU210365B (en) Primary packing for surface stabilized binding material
US20050075595A1 (en) Adhesive dressings
JP2789242B2 (en) How to package sanitary napkins
JP2004515315A (en) Application device
WO1999024341A1 (en) Dispenser for a sterile adhesive bandage
JP2002362584A (en) Packaging bag with management function

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA FI JP KR NO NZ

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2166191

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1994920731

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1994920731

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1994920731

Country of ref document: EP